Dublin, July 28, 2014 (GLOBE NEWSWIRE) -- Research and Markets ( http://www.researchandmarkets.com/research/bj...rheumatoid ) has announced the addition of the "Global Rheumatoid Arthritis Drugs Market 2014-2018" report to their offering.
RA is a chronic disease that leads to inflammation and pain in the human body's joints such as wrists, fingers, knees, feet, and ankles. In addition, it causes inflammation of the tissues that surround the joints and in other organs.
The symptoms of RA begin slowly, usually just mild pain around the joints coupled with stiffness and fatigue, and in the later stages it causes inflammation of the joints. It can occur at any age, even in children, which is called juvenile arthritis. The disease is three times more common in women than in men. Genetic and environmental elements are known to contribute in the development of RA.
The analysts forecast the Global Rheumatoid Arthritis Drugs market will grow at a CAGR of 4.09 percent over the period 2013-2018.
Key Topics Covered:
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
04. Market Research Methodology
05. Introduction
06. Market Landscape
07. Competitive Assessment of Top Drugs
08. Five Forces Analysis
09. Market Segmentation by Category
10. Geographical Segmentation
11. Buying Criteria
12. Rate of Incidence and Prevalence
13. Pipeline Snapshot
14. Market Growth Drivers
15. Drivers and their Impact
16. Market Challenges
17. Impact of Drivers and Challenges
18. Market Trends
19. Trends and their Impact
20. Vendor Landscape
21. Key Vendor Analysis
22. Other Reports in this Series
Companies Mentioned:
- AbbVie Inc.
- Amgen Inc.
- Bristol-Myers Squibb Co.
- F. Hoffmann-La Roche Ltd.
- Janssen Pharmaceuticals Inc.
- Pfizer Inc.
- AB Science SA
- Astellas Pharma Inc.
- AstraZeneca plc
- Biogen Idec Inc.
- Boehringer Ingelheim GmbH
- Celgene Corp.
- Daiichi Sankyo Co. Ltd.
- Eli Lilly & Co.
- GE Healthcare Co.
- Genmab A/S
- GSK plc
- Incyte Corp.
- Merck & Co. Inc.
- Mitsubishi Tanabe Pharma Corp.
- Novartis AG
- Novo Nordisk A/S
- Rigel Pharmaceuticals Inc.
- Sanofi
- Takeda Pharmaceutical Co. Ltd.
- UCB SA
- Vertex Pharmaceuticals Inc.
For more information visit http://www.researchandmarkets.com/research/bj...rheumatoid
Research and Markets Laura Wood, Senior Manager For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Pharmaceuticals
